Company Search:
Advanced Search
Sponsored Links
Pfenex Inc Company Snapshot
Pfenex Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pfenex Inc with three other companies in this sector in the United States: Aduro Biotech Inc (2018 sales of $15.09 million of which 100% was Immunotherapy treatment serives), Arvinas Inc ($14.32 million of which 100% was Biopharmaceutical), and Wave Life Sciences Ltd ($14.41 million of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2018, sales at Pfenex Inc were $14.86 million. This is a sharp decrease of 48.4% versus 2017, when the company's sales were $28.78 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pfenex Inc
  Stock Performance Chart for Pfenex Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 10.67
(Figures in U.S. Dollars)
1 Week 10.3%   13 Weeks 20.2%  
4 Weeks 69.4%   52 Weeks 111.3%  
Pfenex Inc Key Data:
  Ticker: PFNX Country: United States
  Exchanges: NYSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 14,857,000
(Year Ending Jan 2019).
Employees: 71
  Currency: U.S. Dollars Market Cap: 337,146,307
  Fiscal Yr Ends: December Shares Outstanding: 31,597,592
  Share Type: Ordinary Closely Held Shares: 2,937,001
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.